Blepharitis and lid ulcer as initial ocular manifestation in acquired immunodeficiency syndrome patients.
Biswas
J
J
Vision Research Foundation, Chennai, India.
Madhavan
H N
HN
Kumarasamy
N
N
Solomon
S
S
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D000328:Adult; D000900:Anti-Bacterial Agents; D001762:Blepharitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D005141:Eyelid Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D005143:Eyelids / Q000382:microbiology; D005500:Follow-Up Studies; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D008297:Male; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D014456:Ulcer / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology
D000900:Anti-Bacterial Agents